Cardio Diagnostics Correlations
| CDIO Stock | USD 0.27 0.02 8.00% |
The current 90-days correlation between Cardio Diagnostics and Cns Pharmaceuticals is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardio Diagnostics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Cardio Diagnostics Correlation With Market
Weak diversification
The correlation between Cardio Diagnostics Holdings and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and DJI in the same portfolio, assuming nothing else is changed.
Cardio |
Moving together with Cardio Stock
Moving against Cardio Stock
| 0.46 | KZR | Kezar Life Sciences | PairCorr |
| 0.76 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.64 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.64 | HD | Home Depot | PairCorr |
| 0.54 | T | ATT Inc Aggressive Push | PairCorr |
| 0.53 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
| 0.5 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.45 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.35 | VFS | VinFast Auto Earnings Call This Week | PairCorr |
| 0.32 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cardio Stock performing well and Cardio Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cardio Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IMMX | 3.80 | (0.45) | 0.00 | (0.26) | 0.00 | 7.06 | 32.68 | |||
| CNSP | 4.84 | (0.34) | 0.00 | (0.09) | 0.00 | 9.09 | 39.29 | |||
| EFTR | 7.57 | (4.70) | 0.00 | (3.44) | 0.00 | 8.70 | 88.91 | |||
| NAVB | 6.04 | (1.00) | 0.00 | 1.02 | 0.00 | 12.50 | 40.40 | |||
| SONN | 4.76 | (0.77) | 0.00 | 2.22 | 0.00 | 12.31 | 37.58 | |||
| ZURA | 3.80 | (0.37) | 0.00 | (0.08) | 0.00 | 7.95 | 30.69 | |||
| PHIO | 4.64 | (0.24) | 0.00 | (0.09) | 0.00 | 11.78 | 36.22 | |||
| ATNF | 13.05 | 2.84 | 0.39 | 0.55 | 7.34 | 16.10 | 358.73 | |||
| PYXS | 3.72 | (0.57) | 0.00 | (1.35) | 0.00 | 6.41 | 24.27 |
Cardio Diagnostics Corporate Management
| Esq JD | Chief Officer | Profile | |
| Timur Dogan | Chief Officer | Profile | |
| Meeshanthini Dogan | CEO CoFounder | Profile | |
| Khullani JD | Vice Strategy | Profile | |
| MBA JD | CFO Director | Profile |